In GSEA, low CDKN1B expression was associated with genes upregulated in the normal subtype of breast cancer, genes upregulated by mTOR kinase inhibitors, the T-cell receptor signaling pathway, and genes downregulated in memory CD8 T cells (Figure 3A). This evidence concerns the gene CDKN1B and breast carcinoma.